Vaginal Dilator Cervical Cancer Brachytherapy NCT07547267
Summary
A pre-test post-test quasi-experimental clinical trial (NCT07547267) registered with ClinicalTrials.gov investigates the effects of vaginal dilator use on female sexual function, self-compassion level, and quality of life in 80 women undergoing brachytherapy for cervical cancer. Data are collected using the Self-Compassion Scale-Short Form (SCS-SF), Female Sexual Function Scale (FSFI), and EORTC QLQ-C30, with participants evaluated at week 1, week 4, and week 12. The study enrolled participants between June 1, 2025, and February 1, 2026.
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov study record describes a newly registered quasi-experimental trial investigating vaginal dilator use as an intervention in women undergoing brachytherapy for cervical cancer. The study measures three patient-reported outcomes—female sexual function, self-compassion, and quality of life—at three time points over a 12-week period.
For clinical investigators, oncologists, and radiotherapy departments, this trial registration identifies a specific patient-reported outcome research area within cervical cancer survivorship care. It does not create any compliance obligations, nor does it impose any regulatory requirements on affected parties.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Effect of Vaginal Dilator Use
N/A NCT07547267 Kind: NA Apr 23, 2026
Abstract
Objective: This study aimed to investigate the effects of vaginal dilator use on female sexual function, self-compassion level, and quality of life in women undergoing brachytherapy for cervical cancer. Method: The study was conducted using a pre-test post-test quasi-experimental design. The study was conducted with 80 female patients between June 1, 2025, and February 1, 2026. Data were collected using the Patient Identification Form, Self-Compassion Scale-Short Form (SCS-SF), Female Sexual Function Scale (FSFI), and EORTC QLQ-C30. Participants were evaluated at three different time points (week 1, week 4, and week 12).
Conditions: Cervical Cancer, Brachytherapy
Interventions: Vaginal dilator
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.